|
Atomistry » Zinc » PDB 4nuo-4o6s » 4nwk | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 4nuo-4o6s » 4nwk » |
Zinc in PDB 4nwk: Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-ProlinamideProtein crystallography data
The structure of Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide, PDB code: 4nwk
was solved by
J.K.Muckelbauer,
H.E.Klei,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide
(pdb code 4nwk). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide, PDB code: 4nwk: Zinc binding site 1 out of 1 in 4nwkGo back to![]() ![]()
Zinc binding site 1 out
of 1 in the Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide
![]() Mono view ![]() Stereo pair view
Reference:
P.M.Scola,
A.X.Wang,
A.C.Good,
L.Q.Sun,
K.D.Combrink,
J.A.Campbell,
J.Chen,
Y.Tu,
N.Sin,
B.L.Venables,
S.Y.Sit,
Y.Chen,
A.Cocuzza,
D.M.Bilder,
S.D'andrea,
B.Zheng,
P.Hewawasam,
M.Ding,
J.Thuring,
J.Li,
D.Hernandez,
F.Yu,
P.Falk,
G.Zhai,
A.K.Sheaffer,
C.Chen,
M.S.Lee,
D.Barry,
J.O.Knipe,
W.Li,
Y.H.Han,
S.Jenkins,
C.Gesenberg,
Q.Gao,
M.W.Sinz,
K.S.Santone,
T.Zvyaga,
R.Rajamani,
H.E.Klei,
R.J.Colonno,
D.M.Grasela,
E.Hughes,
C.Chien,
S.Adams,
P.C.Levesque,
D.Li,
J.Zhu,
N.A.Meanwell,
F.Mcphee.
Discovery and Early Clinical Evaluation of Bms-605339, A Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor For the Treatment of Hepatitis C Virus Infection. J.Med.Chem. V. 57 1708 2014.
Page generated: Sun Oct 27 03:23:40 2024
ISSN: ISSN 0022-2623 PubMed: 24555570 DOI: 10.1021/JM401840S |
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |